{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T13:54:00Z","timestamp":1783173240369,"version":"3.54.6"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-025-03951-9","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T06:28:28Z","timestamp":1748413708000},"page":"4232-4241","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Two-arm study of sarcopenia in geriatric patients with high-grade glial tumors: temporal muscle thickness and prognostic nutritional index"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3093-0738","authenticated-orcid":false,"given":"Hatice Basaran","family":"Goksen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1321-3465","authenticated-orcid":false,"given":"Alaettin","family":"Arslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8109-8537","authenticated-orcid":false,"given":"Hasan","family":"Erdogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,28]]},"reference":[{"key":"3951_CR1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nox158","author":"QT Ostrom","year":"2017","unstructured":"Ostrom QT, Gittleman H, Liao P, Vecchione-Koval T, Wolinsky Y, Kruchko C, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2010\u20132014. Neuro Oncol. 2017. https:\/\/doi.org\/10.1093\/neuonc\/nox158. (PMID: 29117289; PMCID: PMC5693142).","journal-title":"Neuro Oncol"},{"issue":"10","key":"3951_CR2","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. European organisation for research and treatment of cancer brain tumor and radiotherapy groups; national cancer institute of canada clinical trials group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987\u201396. https:\/\/doi.org\/10.1056\/NEJMoa043330.","journal-title":"N Engl J Med."},{"issue":"4","key":"3951_CR3","doi-asserted-by":"publisher","first-page":"e13062","DOI":"10.1111\/bpa.13062","volume":"32","author":"BT Whitfield","year":"2022","unstructured":"Whitfield BT, Huse JT. Classification of adult-type diffuse gliomas: impact of the world health organization 2021 update. Brain Pathol. 2022;32(4):e13062. https:\/\/doi.org\/10.1111\/bpa.13062. (PMID: 35289001; PMCID: PMC9245936).","journal-title":"Brain Pathol."},{"key":"3951_CR4","doi-asserted-by":"publisher","first-page":"e1026","DOI":"10.1016\/j.wneu.2021.01.028","volume":"149","author":"RS Nunna","year":"2021","unstructured":"Nunna RS, Khalid SI, Patel S, Sethi A, Behbahani M, Mehta AI, et al. Outcomes and patterns of care in elderly patients with glioblastoma multiforme. World Neurosurg. 2021;149:e1026\u201337. https:\/\/doi.org\/10.1016\/j.wneu.2021.01.028. (Epub 2021 Jan 20 PMID: 33482415).","journal-title":"World Neurosurg."},{"issue":"4","key":"3951_CR5","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/ageing\/afq034","volume":"39","author":"AJ Cruz-Jentoft","year":"2010","unstructured":"Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. European working group on Sarcopenia in older people. Sarcopenia: european consensus on definition and diagnosis: report of the european working group on Sarcopenia in older people. Age Ageing. 2010;39(4):412\u201323. https:\/\/doi.org\/10.1093\/ageing\/afq034. (Epub 2010 Apr 13. PMID: 20392703; PMCID: PMC2886201).","journal-title":"Age Ageing."},{"key":"3951_CR6","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ejca.2015.12.030","volume":"57","author":"SS Shachar","year":"2016","unstructured":"Shachar SS, Williams GR, Muss HB, Nishijima TF. Prognostic value of sarcopenia in adults with solid tumours: a meta-analysis and systematic review. Eur J Cancer. 2016;57:58\u201367. https:\/\/doi.org\/10.1016\/j.ejca.2015.12.030. (Epub 2016 Feb 13 PMID: 26882087).","journal-title":"Eur J Cancer."},{"issue":"2","key":"3951_CR7","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2217\/bmm-2022-0748","volume":"17","author":"E Erul","year":"2023","unstructured":"Erul E, Guven DC, Ozbay Y, Altunbulak AY, Kahvecioglu A, Ercan F, et al. Evaluation of sarcopenia as a prognostic biomarker in locally advanced head and neck squamous cell carcinoma. Biomark Med. 2023;17(2):87\u201399. https:\/\/doi.org\/10.2217\/bmm-2022-0748. (E pub 2023 Apr 12. PMID:37042459).","journal-title":"Biomark Med."},{"issue":"12","key":"3951_CR8","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1093\/neuonc\/noz131","volume":"21","author":"J Furtner","year":"2019","unstructured":"Furtner J, Genbrugge E, Gorlia T, Bendszus M, Nowosielski M, Golfinopoulos V, et al. Temporal muscle thickness is an independent prognostic marker in patients with progressive glioblastoma: translational imaging analysis of the EORTC 26101 trial. Neuro Oncol. 2019;21(12):1587\u201394. https:\/\/doi.org\/10.1093\/neuonc\/noz131. (PMID:31369680;PMCID:PMC6917403).","journal-title":"Neuro Oncol."},{"issue":"1","key":"3951_CR9","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s11060-018-2948-8","volume":"140","author":"J Furtner","year":"2018","unstructured":"Furtner J, Berghoff AS, Sch\u00f6pf V, Reumann R, Pascher B, Woitek R, et al. Temporal muscle thickness is an independent prognostic marker in melanoma patients with newly diagnosed brain metastases. J Neurooncol. 2018;140(1):173\u20138. https:\/\/doi.org\/10.1007\/s11060-018-2948-8. (PMID: 30008154; PMCID: PMC6182383).","journal-title":"J Neurooncol."},{"issue":"9","key":"3951_CR10","doi-asserted-by":"publisher","first-page":"6463","DOI":"10.3390\/curroncol29090508","volume":"29","author":"YI Kim","year":"2022","unstructured":"Kim YI, Shin JY, Yang SH, Kim HH, Shim BY, Ahn S. Association between temporal muscle thickness and overall survival in non-small cell lung cancer patients with brain metastasis. Curr Oncol. 2022;29(9):6463\u201371. https:\/\/doi.org\/10.3390\/curroncol29090508. (PMID:36135077;PMCID:PMC9497949).","journal-title":"Curr Oncol."},{"issue":"41","key":"3951_CR11","doi-asserted-by":"publisher","first-page":"e39917","DOI":"10.1097\/MD.0000000000039917","volume":"103","author":"H Deng","year":"2024","unstructured":"Deng H, He Y, Huang G, Huang Y, Wu J, Qin X. Predictive value of prognostic nutritional index in patients undergoing gastrectomy for gastric cancer: a systematic review and meta-analysis. Med (Baltimore). 2024;103(41):e39917. https:\/\/doi.org\/10.1097\/MD.0000000000039917. (PMID:39465872;PMCID:PMC11479530).","journal-title":"Med (Baltimore)."},{"issue":"18","key":"3951_CR12","doi-asserted-by":"publisher","first-page":"5636","DOI":"10.26355\/eurrev_202109_26783","volume":"25","author":"Q Zhang","year":"2021","unstructured":"Zhang Q, Bao J, Zhu ZY, Jin MX. Prognostic nutritional index as a prognostic factor in lung cancer patients receiving chemotherapy: a systematic review and meta-analysis. Eur Rev Med Pharmacol Sci. 2021;25(18):5636\u201352. https:\/\/doi.org\/10.26355\/eurrev_202109_26783. (PMID: 34604956).","journal-title":"Eur Rev Med Pharmacol Sci."},{"issue":"1","key":"3951_CR13","doi-asserted-by":"publisher","first-page":"17117","DOI":"10.1038\/s41598-021-96598-9","volume":"11","author":"CW Luan","year":"2021","unstructured":"Luan CW, Tsai YT, Yang HY, Chen KY, Chen PH, Chou HH. Pretreatment prognostic nutritional index as a prognostic marker in head and neck cancer: a systematic review and meta-analysis. Sci Rep. 2021;11(1):17117. https:\/\/doi.org\/10.1038\/s41598-021-96598-9. (PMID:34429476;PMCID:PMC8385102).","journal-title":"Sci Rep."},{"issue":"8","key":"3951_CR14","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s11547-022-01524-2","volume":"127","author":"F Pasqualetti","year":"2022","unstructured":"Pasqualetti F, Gabelloni M, Gonnelli A, Faggioni L, Cantarella M, Montrone S, et al. Impact of temporalis muscle thickness in elderly patients with newly diagnosed glioblastoma treated with radio or radio-chemotherapy. Radiol Med. 2022;127(8):919\u201324. https:\/\/doi.org\/10.1007\/s11547-022-01524-2. (Epub 2022 Jul 18 PMID: 35849309).","journal-title":"Radiol Med."},{"key":"3951_CR15","doi-asserted-by":"publisher","first-page":"e448","DOI":"10.1016\/j.wneu.2022.02.038","volume":"161","author":"RA Morshed","year":"2022","unstructured":"Morshed RA, Young JS, Casey M, Wang EJ, Aghi MK, Berger MS, et al. Sarcopenia diagnosed using masseter muscle diameter as a survival correlate in elderly patients with glioblastoma. World Neurosurg. 2022;161:e448\u201363. https:\/\/doi.org\/10.1016\/j.wneu.2022.02.038. (PMID: 35181534; PMCID: PMC9284942).","journal-title":"World Neurosurg."},{"key":"3951_CR16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043330","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. European organisation for research and treatment of cancer brain tumor and radiotherapy groups; national cancer institute of Canada clinical trials group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005. https:\/\/doi.org\/10.1056\/NEJMoa043330.","journal-title":"N Engl J Med"},{"key":"3951_CR17","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdac038","author":"MPG Broen","year":"2022","unstructured":"Broen MPG, Beckers R, Willemsen ACH, Huijs SMH, Pasmans RCOS, Eekers DBP, et al. Temporal muscle thickness as an independent prognostic imaging marker in newly diagnosed glioblastoma patients: a validation study. Neurooncol Adv. 2022. https:\/\/doi.org\/10.1093\/noajnl\/vdac038. (PMID: 35475275; PMCID: PMC9034111).","journal-title":"Neurooncol Adv"},{"issue":"11","key":"3951_CR18","doi-asserted-by":"publisher","first-page":"e0207849","DOI":"10.1371\/journal.pone.0207849","volume":"13","author":"J Leitner","year":"2018","unstructured":"Leitner J, Pelster S, Sch\u00f6pf V, Berghoff AS, Woitek R, Asenbaum U, et al. High correlation of temporal muscle thickness with lumbar skeletal muscle cross-sectional area in patients with brain metastases. PLoS One. 2018;13(11):e0207849. https:\/\/doi.org\/10.1371\/journal.pone.0207849. (PMID:30496307;PMCID:PMC6264824).","journal-title":"PLoS One."},{"issue":"8","key":"3951_CR19","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.1007\/s00330-016-4707-6","volume":"27","author":"J Furtner","year":"2017","unstructured":"Furtner J, Berghoff AS, Albtoush OM, Woitek R, Asenbaum U, Prayer D, et al. Survival prediction using temporal muscle thickness measurements on cranial magnetic resonance images in patients with newly diagnosed brain metastases. Eur Radiol. 2017;27(8):3167\u201373. https:\/\/doi.org\/10.1007\/s00330-016-4707-6. (Epub 2017 Jan 3. PMID: 28050694; PMCID: PMC5491578).","journal-title":"Eur Radiol."},{"issue":"1","key":"3951_CR20","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/0002-9610(80)90246-9","volume":"139","author":"GP Buzby","year":"1980","unstructured":"Buzby GP, Mullen JL, Matthews DC, Hobbs CL, Rosato EF. Prognostic nutritional index in gastrointestinal surgery. Am J Surg. 1980;139(1):160\u20137. https:\/\/doi.org\/10.1016\/0002-9610(80)90246-9. (PMID: 7350839).","journal-title":"Am J Surg."},{"issue":"25","key":"3951_CR21","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1056\/NEJMra1712502","volume":"379","author":"CL Shapiro","year":"2018","unstructured":"Shapiro CL. Cancer survivorship. N Engl J Med. 2018;379(25):2438\u201350. https:\/\/doi.org\/10.1056\/NEJMra1712502. (PMID: 30575480).","journal-title":"N Engl J Med."},{"key":"3951_CR22","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.clnesp.2025.01.043","volume":"66","author":"I Morelli","year":"2025","unstructured":"Morelli I, Greto D, Visani L, Lombardi G, Scorsetti M, Clerici E, et al. Integrating nutritional status and hematological biomarkers for enhanced prognosis prediction in glioma patients: a systematic review. Clin Nutr ESPEN. 2025;66:269\u201380. https:\/\/doi.org\/10.1016\/j.clnesp.2025.01.043. (Epub 2025 Jan 24 PMID: 39864522).","journal-title":"Clin Nutr ESPEN."},{"issue":"1","key":"3951_CR23","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1055\/s-0044-1779050","volume":"86","author":"K Song","year":"2024","unstructured":"Song K, Chen C, Xu H, Chen L, Xu H, Han X, et al. Prediction of survival in the elderly patients with glioblastoma using cumulative inflammatory markers score. J Neurol Surg B Skull Base. 2024;86(1):98\u2013105. https:\/\/doi.org\/10.1055\/s-0044-1779050. (PMID:39881741;PMCID:PMC11774615).","journal-title":"J Neurol Surg B Skull Base."},{"key":"3951_CR24","doi-asserted-by":"publisher","first-page":"e865","DOI":"10.1016\/j.wneu.2020.11.033","volume":"146","author":"S Huq","year":"2021","unstructured":"Huq S, Khalafallah AM, Botros D, Oliveira LAP, White T, Dux H, et al. The prognostic impact of nutritional status on postoperative outcomes in glioblastoma. World Neurosurg. 2021;146:e865\u201375. https:\/\/doi.org\/10.1016\/j.wneu.2020.11.033. (Epub 2020 Nov 13 PMID: 33197633).","journal-title":"World Neurosurg."},{"issue":"9","key":"3951_CR25","doi-asserted-by":"publisher","first-page":"886","DOI":"10.3389\/fphar.2018.00886","volume":"14","author":"PF Wang","year":"2018","unstructured":"Wang PF, Meng Z, Song HW, Yao K, Duan ZJ, Yu CJ, et al. Preoperative Changes in Hematological Markers and Predictors of Glioma Grade and Survival. Front Pharmacol. 2018;14(9):886. https:\/\/doi.org\/10.3389\/fphar.2018.00886. (PMID:30154718;PMCID:PMC6103192).","journal-title":"Front Pharmacol."},{"issue":"1","key":"3951_CR26","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1186\/s12885-023-10889-0","volume":"23","author":"X Duan","year":"2023","unstructured":"Duan X, Yang B, Zhao C, Tie B, Cao L, Gao Y. Prognostic value of preoperative hematological markers in patients with glioblastoma multiforme and construction of random survival forest model. BMC Cancer. 2023;23(1):432. https:\/\/doi.org\/10.1186\/s12885-023-10889-0. (PMID:37173662;PMCID:PMC10176909).","journal-title":"BMC Cancer."},{"issue":"1","key":"3951_CR27","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1186\/s12885-021-08686-8","volume":"21","author":"YJ Kim","year":"2021","unstructured":"Kim YJ, Oh H, Lee SJ, Kim KM, Kang H, Park CK, et al. Prognostic significance of the postoperative prognostic nutritional index in patients with glioblastoma: a retrospective study. BMC Cancer. 2021;21(1):942. https:\/\/doi.org\/10.1186\/s12885-021-08686-8. (PMID:34418999;PMCID:PMC8380354).","journal-title":"BMC Cancer."},{"issue":"1","key":"3951_CR28","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.neucie.2020.11.004","volume":"33","author":"O Alan","year":"2022","unstructured":"Alan O, Telli TA, Baso\u011flu T, Arikan R, Demircan NC, Ercelep O, et al. Impact of prognostic nutritional index on survival in recurrent glioblastoma. Neurocirugia (Eng Ed). 2022;33(1):15\u201321. https:\/\/doi.org\/10.1016\/j.neucie.2020.11.004. (PMID: 34998488).","journal-title":"Neurocirugia (Eng Ed)."},{"key":"3951_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2023.112077","author":"YW Yang","year":"2023","unstructured":"Yang YW, Yang Ming, Zhou YW, Xia X, Jia SL, Zhao YL, et al. Prognostic value of temporal muscle thickness a novel radiographic marker of sarcopenia in patients with brain tumor: a systematic review and meta-analysis. Nutrition. 2023. https:\/\/doi.org\/10.1016\/j.nut.2023.112077. (Epub 2023 May 11. PMID: 37236042).","journal-title":"Nutrition"},{"issue":"3","key":"3951_CR30","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s11060-022-04180-8","volume":"160","author":"C Ten Cate","year":"2022","unstructured":"Ten Cate C, Huijs SMH, Willemsen ACH, Pasmans RCOS, Eekers DBP, Zegers CML, et al. Correlation of reduced temporal muscle thickness and systemic muscle loss in newly diagnosed glioblastoma patients. J Neurooncol. 2022;160(3):611\u20138. https:\/\/doi.org\/10.1007\/s11060-022-04180-8. (Epub 2022 Nov 17. PMID: 36394717; PMCID: PMC9758090).","journal-title":"J Neurooncol."},{"issue":"6","key":"3951_CR31","doi-asserted-by":"publisher","first-page":"4079","DOI":"10.1007\/s00330-020-07471-8","volume":"31","author":"R Muglia","year":"2021","unstructured":"Muglia R, Simonelli M, Pessina F, Morenghi E, Navarria P, Persico P, et al. Prognostic relevance of temporal muscle thickness as a marker of sarcopenia in patients with glioblastoma at diagnosis. Eur Radiol. 2021;31(6):4079\u201386. https:\/\/doi.org\/10.1007\/s00330-020-07471-8. (Epub 2020 Nov 17. PMID: 33201284).","journal-title":"Eur Radiol."},{"issue":"13","key":"3951_CR32","doi-asserted-by":"publisher","first-page":"1237105","DOI":"10.3389\/fonc.2023.1237105","volume":"31","author":"J Klingenschmid","year":"2023","unstructured":"Klingenschmid J, Krigers A, Sch\u00f6n V, Pinggera D, Kerschbaumer J, Grams AE, et al. Temporal muscle thickness has no prognostic relevance in patients with high-grade glioma compared to functional scales. Front Oncol. 2023;31(13):1237105. https:\/\/doi.org\/10.3389\/fonc.2023.1237105. (PMID: 37727210; PMCID: PMC10506078).","journal-title":"Front Oncol."}],"updated-by":[{"DOI":"10.1007\/s12094-025-03977-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000}}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-025-03951-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-025-03951-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-025-03951-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:02:28Z","timestamp":1761627748000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-025-03951-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,28]]},"references-count":32,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["3951"],"URL":"https:\/\/doi.org\/10.1007\/s12094-025-03951-9","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,28]]},"assertion":[{"value":"20 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised to correct the TMT units as 'mm' in Abstract section, Fig. 2 caption, Table 1, Results section, Figures 3 and 4.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2025","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s12094-025-03977-z","URL":"https:\/\/doi.org\/10.1007\/s12094-025-03977-z","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Kayseri City Education and Research Hospital (24.12.2024\/278).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}